Wall Street Analysts See a 68.59% Upside in CorMedix (CRMD): Can the Stock Really Move This High?

CorMedix (CRMD) closed the last trading session at $12.16, gaining 7.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 20.5 indicates a 68.6% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $2.07. While the lowest estimate of$ 17.00 indicates a 39.8% increase from the current price level, the most optimistic analyst expects t ...